Calypsa Competitors

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

The ZETA Group is an end-to-end solution provider operating globally and specializing in the design, construction, automation, digitization and qualification of customer-specific biopharmaceutical systems for aseptic process solutions. ZETA provides support after commissioning of the process equipment through targeted ramp-up as well as service and maintenance along the entire product lifecyle. True to the principle of continuous improvement, ZETA guides customers during process and system optimization as well as operator training. As general planners (EPCM), ZETA manages major, high-complexity pharma projects and specifically reduces interfaces—from the planning and construction of the process system through the cleanroom design up to the technical building infrastructure. This design-build approach accelerates the project execution time by up to 50% and leads to creation of value earlier in the customer’s capex projects. In the field of digitization, ZETA’s fully integrated digital value chain—from engineering through qualification and operator management—has established the company as an innovation driver in the pharma and biotech industry. ZETA is also actively taking steps towards a more sustainable future for the entire industry: By holistic decarbonization strategies that reduce targeted emissions during the biopharmaceutical manufacturing process. Your reliable partner for biopharmaceutical projects: • EPCMv contractor • Plant engineering • HVAC-, cleanroom and BMS/EMS design • Decarbonization • Automation • Digitalisation • Qualification • Maintenance & Upgrades • Research & Development Legal Notice: https://www.zeta.com/legal-notice/ Data Protection: https://www.zeta.com/data-protection/

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.